BRN.AX BrainChip (ASX) A$0.155 pre-market 31 Jan 2026: AI edge uptake under watch
BRN.AX stock opens pre-market at A$0.155 on 31 Jan 2026 after a 1-day drop of -6.06%. Trading volume has surged to 17,122,800 shares, roughly double the average volume of 8,437,271. BrainChip Holdings Ltd (ASX) remains a small-cap AI semiconductor play focused on the Akida neuromorphic processor for low-power edge applications. Investors are weighing product adoption news and tight financials ahead of the next earnings date on 4 March 2026.
BRN.AX stock: intraday price, liquidity and recent moves
The pre-market price reads A$0.155 after an open at A$0.165 and a previous close of A$0.165. Volume today is 17,122,800 versus average volume 8,437,271, giving a relative volume of 1.998. The stock sits at its 52-week low of A$0.155 with a year high of A$0.340, highlighting wide volatility. Short-term momentum metrics show RSI 60.30 and CCI 137.05, suggesting recent buying pressure after prior selling.
Financials and valuation: margins, cash and ratios
BrainChip reports trailing EPS of -0.02 and a negative PE of -7.75, reflecting recurring losses. Key ratio snapshots: current ratio 5.18, cash per share 0.00647, and price-to-book near 14.87. Free cash flow remains negative at -0.00702 per share TTM, but the company shows low debt with debt-to-equity 0.07. The high price-to-sales and EV-to-sales multiples indicate the market prices growth expectations, not current revenue scale.
Sector context for BRN.AX stock: technology and semiconductors
BrainChip trades in the Technology sector and Semiconductors industry on the ASX. The ASX Technology sector shows one-year gains of 24.04%, while semiconductor peers show stronger capital intensity. Compared to sector averages, BRN.AX has weaker profitability and higher volatility. Sector trends favour edge AI hardware, which supports BrainChip’s product narrative but raises competitive and execution risks.
Technical outlook and trading signals for BRN.AX stock
Technical indicators flag mixed signals. Bollinger Bands sit 0.15 to 0.19 with the middle band 0.17. Momentum metrics include ROC 15.62% and Stochastic %K 90.48, indicating short-term strength but possible overbought conditions. ADX 19.05 suggests no strong trend. Traders may watch a break above A$0.17 for near-term confirmation or a close below A$0.155 for further downside.
News flow, catalysts and risks affecting BRN.AX stock
Key catalysts: Akida customer design wins, volume manufacturing updates, and the earnings release on 4 Mar 2026. Risks include continued negative earnings, slow enterprise adoption, and dilution from equity raises. Market commentary and delayed US quotes have created occasional liquidity gaps source. For broader Australian AI hardware commentary see related ASX listings and sector reports source.
Meyka AI grade and model forecast for BRN.AX stock
Meyka AI rates BRN.AX with a score out of 100: Score: 64.95 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price of A$0.1904, a quarterly target A$0.21, and a monthly of A$0.11. Compared to the current price A$0.155, the yearly projection implies an upside of 22.83%, while the monthly model implies downside near -29.03%. Forecasts are model-based projections and not guarantees.
Final Thoughts
BRN.AX stock trades at A$0.155 pre-market on 31 Jan 2026 with heavy volume. The core investment case hinges on Akida neuromorphic adoption for low-power edge AI, not on near-term profits. Financials show negative EPS and stretched valuation ratios, while a strong current ratio and low debt reduce solvency risk. Technicals give mixed signals with momentum but no clear trend. Meyka AI’s model projects a yearly target of A$0.1904, implying +22.83% from A$0.155, but shorter-term models show downside risk to A$0.11. Use earnings on 4 March 2026 and any product adoption updates as decision points. Meyka AI-powered market analysis can help monitor catalysts and intraday flows, but investors should treat forecasts as model outputs, not guarantees.
FAQs
What is the current price of BRN.AX stock?
BRN.AX stock trades pre-market at A$0.155 on 31 Jan 2026. Today’s volume is 17,122,800, roughly double the average. Price has declined about -6.06% on the day.
What catalysts could move BRN.AX stock in 2026?
Primary catalysts are Akida customer design wins, production scale updates, and the earnings report on 4 Mar 2026. Positive adoption news could validate revenue growth and lift the stock.
What price targets does Meyka AI give for BRN.AX stock?
Meyka AI’s forecast model projects a yearly price of A$0.1904 and a quarterly target of A$0.21. The yearly model implies +22.83% versus current A$0.155. Forecasts are not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
